Paraspinous Anesthetic Block for Non-Responsive Pelvic Pain
CompletedPhase 4NCT01635205
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
This study examines randomized triple-blind clinical trial and the efficacy of paraspinous anesthetic block on the treatment of chronic pelvic pain in patients non-responsive to pharmacological management. Sixty patients will be randomly divided and allocated into group intervention (paraspinous anesthetic block) and control (placebo procedure in subcutaneous tissue).
Study details
- Official title
- Efficacy of Paraspinous Anesthetic Block in Patients With Chronic Pelvic Pain Non-Responsive to Pharmacological Treatment
- Conditions
- Paraspinous Block
- Pelvis Pain Chronic
- Interventions
- Procedure: paraspinous anesthetic block
- Procedure: subcutaneous puncture with no anesthetic effect
- Sponsor
- Hospital de Clinicas de Porto Alegre
- Start date
- 2011-10
- Primary completion
- 2013-05
- Sex
- Female
- Age range
- from 18 Years
- Results posted
- No results posted in this snapshot
- Countries
- Brazil
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Patients with benign pelvic pain non-responsive to pharmacological treatment, lasting at least 6 months, located in the anatomic pelvis, anterior abdominal wall, infra-umbilical region, lumbossacral region or buttocks. Pain must be hard enough to cause functional impairment or to motivate medical counseling. The absence of physical findings does not decreases the importance of pain, nether excludes the possibility of pelvic pathology. Exclusion Criteria: * Patients who do not want to take part in the study * Age under 18 years old * Pelvic pain lasting less than 6 months * Relief or resolution of pain with pharmacological treatment * Pain of neoplastic origin * Known allergy or report of adverse reaction related to lidocaine
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT01635205